The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 22, 2022
Filed:
Feb. 10, 2017
Applicant:
Albert Mihranyan, Uppsala, SE;
Inventor:
Albert Mihranyan, Uppsala, SE;
Assignee:
Other;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/717 (2006.01); A61K 31/192 (2006.01); A61K 9/14 (2006.01); A61K 31/405 (2006.01); A61K 31/565 (2006.01); A61K 31/5415 (2006.01); A61K 31/196 (2006.01); A61K 9/16 (2006.01); A61P 29/00 (2006.01); A61K 31/166 (2006.01); A61K 31/57 (2006.01);
U.S. Cl.
CPC ...
A61K 31/717 (2013.01); A61K 9/146 (2013.01); A61K 9/16 (2013.01); A61K 31/192 (2013.01); A61K 31/196 (2013.01); A61K 31/405 (2013.01); A61K 31/5415 (2013.01); A61K 31/565 (2013.01); A61K 31/166 (2013.01); A61K 31/57 (2013.01); A61K 2300/00 (2013.01); A61P 29/00 (2018.01);
Abstract
There is provided a pharmaceutical composition comprising cellulose obtained from algae, or a derivative of said cellulose, and an active pharmaceutical ingredient (e.g. from Type 2 and 4 BCS class), wherein the active pharmaceutical ingredient is in a predominantly amorphous form. Compositions of the invention find particularly utility as formulations comprising BCS Type 2 and 4 drugs, including NSAIDs or other drugs, that may be employed in the treatment of migraine or dysmenorrhea, as well as formulations comprising other poorly soluble active ingredients where rapid release in vivo is advantageous.